Log in to save to my catalogue

Metformin reverses stem cell‑like HepG2 sphere formation and resistance to sorafenib by attenuating...

Metformin reverses stem cell‑like HepG2 sphere formation and resistance to sorafenib by attenuating...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6131649

Metformin reverses stem cell‑like HepG2 sphere formation and resistance to sorafenib by attenuating epithelial‑mesenchymal transformation

About this item

Full title

Metformin reverses stem cell‑like HepG2 sphere formation and resistance to sorafenib by attenuating epithelial‑mesenchymal transformation

Publisher

Greece: Spandidos Publications

Journal title

Molecular medicine reports, 2018-10, Vol.18 (4), p.3866-3872

Language

English

Formats

Publication information

Publisher

Greece: Spandidos Publications

More information

Scope and Contents

Contents

Cancer stem cells (CSCs) have been reported to be associated with the recurrence and drug resistance of liver cancer. In the present study, stem cell‑like HepG2 cell spheres were enriched using stem cell conditioned culture medium. As expected, stem‑like HepG2 cell spheres exhibited increased resistance to sorafenib. Metformin, a common drug used t...

Alternative Titles

Full title

Metformin reverses stem cell‑like HepG2 sphere formation and resistance to sorafenib by attenuating epithelial‑mesenchymal transformation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6131649

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6131649

Other Identifiers

ISSN

1791-2997

E-ISSN

1791-3004

DOI

10.3892/mmr.2018.9348

How to access this item